185 related articles for article (PubMed ID: 15078918)
1. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
Kurata HT; Wang Z; Fedida D
J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
[TBL] [Abstract][Full Text] [Related]
2. Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating.
Yao JA; Saxena NC; Ziai MR; Ling S; Tseng GN
Mol Pharmacol; 1995 Jul; 48(1):160-71. PubMed ID: 7623770
[TBL] [Abstract][Full Text] [Related]
3. Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channel.
Rampe D; Wang Z; Fermini B; Wible B; Dage RC; Nattel S
J Pharmacol Exp Ther; 1995 Jul; 274(1):444-9. PubMed ID: 7616429
[TBL] [Abstract][Full Text] [Related]
4. 4-Aminopyridine binding and slow inactivation are mutually exclusive in rat Kv1.1 and Shaker potassium channels.
Castle NA; Fadous SR; Logothetis DE; Wang GK
Mol Pharmacol; 1994 Dec; 46(6):1175-81. PubMed ID: 7808439
[TBL] [Abstract][Full Text] [Related]
5. NIP domain prevents N-type inactivation in voltage-gated potassium channels.
Roeper J; Sewing S; Zhang Y; Sommer T; Wanner SG; Pongs O
Nature; 1998 Jan; 391(6665):390-3. PubMed ID: 9450755
[TBL] [Abstract][Full Text] [Related]
6. Properties of the Kv1.1 rat brain potassium channels expressed in mammalian cells: temperature effects.
Moran O; Conti F
Biochem Biophys Res Commun; 1995 Oct; 215(3):915-20. PubMed ID: 7488061
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel.
Malayev AA; Nelson DJ; Philipson LH
Mol Pharmacol; 1995 Jan; 47(1):198-205. PubMed ID: 7838129
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity.
Zhang H; Zhu B; Yao JA; Tseng GN
J Pharmacol Exp Ther; 1998 Oct; 287(1):332-43. PubMed ID: 9765354
[TBL] [Abstract][Full Text] [Related]
9. NMR structure of inactivation gates from mammalian voltage-dependent potassium channels.
Antz C; Geyer M; Fakler B; Schott MK; Guy HR; Frank R; Ruppersberg JP; Kalbitzer HR
Nature; 1997 Jan; 385(6613):272-5. PubMed ID: 9000078
[TBL] [Abstract][Full Text] [Related]
10. Separable effects of human Kvbeta1.2 N- and C-termini on inactivation and expression of human Kv1.4.
Accili EA; Kuryshev YA; Wible BA; Brown AM
J Physiol; 1998 Oct; 512 ( Pt 2)(Pt 2):325-36. PubMed ID: 9763623
[TBL] [Abstract][Full Text] [Related]
11. Structural determinants of quaternary ammonium blockers for batrachotoxin-modified Na+ channels.
Wang GK; Simon R; Bell D; Mok WM; Wang SY
Mol Pharmacol; 1993 Sep; 44(3):667-76. PubMed ID: 8396721
[TBL] [Abstract][Full Text] [Related]
12. Modulation of C-type inactivation by K+ at the potassium channel selectivity filter.
Kiss L; Korn SJ
Biophys J; 1998 Apr; 74(4):1840-9. PubMed ID: 9545046
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states.
Jäger H; Rauer H; Nguyen AN; Aiyar J; Chandy KG; Grissmer S
J Physiol; 1998 Jan; 506 ( Pt 2)(Pt 2):291-301. PubMed ID: 9490854
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes in a mammalian voltage-dependent potassium channel inactivation peptide.
Abbott GW; Mercer EA; Miller RT; Ramesh B; Srai SK
Biochemistry; 1998 Feb; 37(6):1640-5. PubMed ID: 9484235
[TBL] [Abstract][Full Text] [Related]
15. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5.
Bouchard R; Fedida D
J Pharmacol Exp Ther; 1995 Nov; 275(2):864-76. PubMed ID: 7473178
[TBL] [Abstract][Full Text] [Related]
16. Evidence for interaction between transmembrane segments in assembly of Kv1.3.
Sheng Z; Skach W; Santarelli V; Deutsch C
Biochemistry; 1997 Dec; 36(49):15501-13. PubMed ID: 9398279
[TBL] [Abstract][Full Text] [Related]
17. Blockade of sodium and potassium channels in the node of Ranvier by ajmaline and N-propyl ajmaline.
Khodorov BI; Zaborovskaya LD
Gen Physiol Biophys; 1983 Aug; 2(4):233-68. PubMed ID: 6088360
[TBL] [Abstract][Full Text] [Related]
18. A voltage-dependent role for K+ in recovery from C-type inactivation.
Levy DI; Deutsch C
Biophys J; 1996 Dec; 71(6):3157-66. PubMed ID: 8968586
[TBL] [Abstract][Full Text] [Related]
19. Frequency-dependent inactivation of mammalian A-type K+ channel KV1.4 regulated by Ca2+/calmodulin-dependent protein kinase.
Roeper J; Lorra C; Pongs O
J Neurosci; 1997 May; 17(10):3379-91. PubMed ID: 9133364
[TBL] [Abstract][Full Text] [Related]
20. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.
Caballero R; Delpón E; Valenzuela C; Longobardo M; Franqueza L; Tamargo J
Br J Pharmacol; 1997 Nov; 122(5):796-8. PubMed ID: 9384491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
